Page 10 - Raju Prasad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Raju prasad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Raju Prasad Today - Breaking & Trending Today

AstraZeneca throws lifeline to gene-editing biotech LogicBio with $68M buyout

AstraZeneca’s LogicBio acquisition comes at a critical time for the biotech. Though LogicBio has encouraging early clinical data for its lead gene-editing therapeutic candidate, the company’s cash woes include a flagging stock price that is set to lose its listing on the Nasdaq. ....

United States , Marc Dunoyer , Raju Prasad , William Blair , Alexion Pharmaceuticals , Astrazeneca Rare Disease , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness , Mployee Wellness Programs ,

Rocket Pharma stocks up on cardiac gene therapies with $53M Renovacor acquisition

Rocket Pharmaceuticals is acquiring Renovacor, a gene therapies developer whose lead program addresses a particular genetic mutation that leads to a type of heart failure. The all-stock deal gives Rocket the opportunity to expand its reach in genetically driven cardiac diseases. ....

United Kingdom , Arthur Feldman , Gaurav Shah , Raju Prasad , William Blair , York Stock Exchange , Rocket Pharmaceuticals , New York Stock Exchange , Temple University , Massachusetts Based Renovacor , New Jersey Based , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company ,

Bluebird Bio gene therapy becomes first FDA-approved med for ultra-rare neuro disorder

Bluebird Bio gene therapy Skysona has won FDA approval, making it the first FDA-approved therapy for cerebral adrenoleukodystrophy, an ultra-rare and fatal neurological disorder. Skysona’s regulatory green light follows the August approval of Zynteglo, a Bluebird gene therapy for a rare blood disorder. ....

United States , Andrew Obenshain , Raju Prasad , William Blair , Rocket Pharmaceuticals , European Commission , Bluebird Bio , Massachusetts Based Bluebird , Boston Children , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery ,

Another Intellia CRISPR therapy flashes potential for one-time, in vivo treatment

Intellia Therapeutics has encouraging early clinical data for a gene-editing therapy addressing the rare swelling disorder hereditary angioedema. This therapy, the biotech’s second CRISPR-editing based treatment that performs in vivo edits, offers potential for a one-time treatment of a disease that is currently addressed by chronic oral and injectable drugs. ....

United Kingdom , William Blair Prasad , Raju Prasad , William Blair , Biocryst Pharmaceuticals , American College Of Allergy , Ionis Pharmaceuticals , Kalvista Pharmaceuticals , Intellia Therapeutics , Massachusetts Based Intellia , Takeda Pharmaceutical , American College , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens ,

Poseida Therapeutics: Global Collaboration Agreement With Roche

Poseida announced a strategic global collaboration agreement with Roche potentially worth up to $6 billion. See why I feel PSTX stock appears undervalued. ....

United States , San Diego , Roche Poseida , Eric Ostertag , Charles Baum , William Blair Raju Prasad , Finsmes Poseida Thereapeutics , Cynthia Collins , Mark Gergen , Susan Slovin , Alec Stranahan , Piper Sandler Edward Tenthoff , Cantor Fitzgerald Jennifer Kim , Takeda Poseida , Head Of Research , Roche Poseida Global Partnership , Poseida Therapeutics Inc , Takeda Pharmaceutical Company Ltd , Strategic Partnership , Memorial Sloan Kettering Cancer Center On , San Poseida Therapeutics Inc , Poseida Differentiated Technology , Takeda Strategic Partnership , Halozyme Inc , F Hoffmann La Roche Ltd , Roche Inc ,